Title:
TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS AND NON-ALCOHOLIC FATTY LIVER DISEASE
Document Type and Number:
WIPO Patent Application WO/2023/250211
Kind Code:
A3
Abstract:
Methods and compositions comprising one or more dopamine neuronal activity enhancers (e.g., dopamine receptor agonists), pantethine and solubilized curcumin for use in treating NAFLD and NASH are provided.
Inventors:
CINCOTTA ANTHONY H (US)
Application Number:
PCT/US2023/026236
Publication Date:
February 22, 2024
Filing Date:
June 26, 2023
Export Citation:
Assignee:
VEROSCIENCE LLC (US)
International Classes:
A61P1/16; A61P3/00; A61P3/04; A61P3/10
Domestic Patent References:
| WO2020011854A1 | 2020-01-16 |
Foreign References:
| US20190054046A1 | 2019-02-21 | |||
| US20090110674A1 | 2009-04-30 |
Other References:
TAVARES RENATA LEITE, DE ARAÚJO VASCONCELOS MARIA HELENA, DORAND VICTOR AUGUSTO MATHIAS, TORRES JUNIOR EMANUEL UBALDINO, TAVARES T: "Mucuna pruriens treatment shows anti-obesity and intestinal health effects in obese rats", FOOD & FUNCTION, vol. 12, no. 14, 20 July 2021 (2021-07-20), GB , pages 6479 - 6489, XP093145057, ISSN: 2042-6496, DOI: 10.1039/D0FO03261A
Attorney, Agent or Firm:
SULLIVAN, JR., Robert, C. et al. (US)
Download PDF:
Previous Patent: CHEMICALLY RECYCLABLE POLYMERS, METHODS OF MAKING SAME, AND USES THEREOF
Next Patent: EXPRESSION MICRODISSECTION SYSTEMS
Next Patent: EXPRESSION MICRODISSECTION SYSTEMS